Department of Pediatrics, Central People's Hospital of Zhanjiang, Zhanjiang, 524045, Guangdong, China.
Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524045, Guangdong, China.
Neurochem Res. 2023 Sep;48(9):2870-2880. doi: 10.1007/s11064-023-03951-7. Epub 2023 May 19.
A growing body of evidence has shown that seizure can trigger inflammatory cascades through increasing the expression of several inflammatory cytokines. It has been proved that peroxisome proliferator-activated receptor-γ agonists have immunomodulatory, anti-inflammatory, and neuroprotective effects beyond the putative hypoglycemic effects. Thus, we investigated the inhibitory effect of rosiglitazone on the development of pentylenetetrazol (PTZ)-induced kindling via affecting the inflammatory pathway. Male C57BL/6 mice were randomly divided into vehicle group (0.1% DMSO), PTZ-group and rosiglitazone-PTZ-group. Kindling was induced by the administration of PTZ (40 mg/kg, i.p) every other day and mice were observed for 20 min after each PTZ injection. Twenty-four hours after the last dose, animals were euthanized and hippocampus was isolated. The level of Malondialdehyde (MDA), Superoxide Dismutase (SOD), and Catalase (CAT) activity were quantified in hippocampus by biochemical methods. The protein levels of IL-1β, IL-6, IL-10, IFN-γ, TNF-α, caspase-3, iNOS, PPAR-γ, Bcl-2, or Bax factors were measured with western blotting. Also, the quantitative real-time PCR were used to evaluate the mRNA expression of those factors. Pretreatment with rosiglitazone significantly prevented the progression of kindling in comparison with control group. The rosiglitazone significantly decreased the MDA level and increased the CAT, and SOD levels in the rosiglitazone treated mice compared to those in the PTZ group (P < 0.01). Using real-time PCR and Western blotting assay, similar results were obtained. The expression levels of IL-1β, IL-6, IL-10, IFN-γ, TNF-α, Bax or PPAR-γ were significantly changed in the brain. The results of this study suggest that effect of rosiglitazone may be crucial in its ability to protect against the neuronal damage caused by PTZ induced seizure.
越来越多的证据表明,癫痫发作可通过增加几种炎症细胞因子的表达引发炎症级联反应。已经证明过氧化物酶体增殖物激活受体-γ激动剂除了潜在的降血糖作用外,还具有免疫调节、抗炎和神经保护作用。因此,我们通过影响炎症途径,研究了罗格列酮对戊四氮(PTZ)诱导的点燃发展的抑制作用。雄性 C57BL/6 小鼠被随机分为对照组(0.1%DMSO)、PTZ 组和罗格列酮-PTZ 组。每隔一天腹腔注射 PTZ(40mg/kg)诱导点燃,每次 PTZ 注射后观察 20 分钟。最后一次给药后 24 小时,处死动物并分离海马。通过生化方法定量测定海马中的丙二醛(MDA)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性。用 Western blot 法测定海马中白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)、半胱氨酸天冬氨酸蛋白酶-3(caspase-3)、诱导型一氧化氮合酶(iNOS)、过氧化物酶体增殖物激活受体-γ(PPAR-γ)、B 细胞淋巴瘤/白血病-2(Bcl-2)或 Bax 因子的蛋白水平。还使用实时定量 PCR 评估这些因子的 mRNA 表达。与对照组相比,罗格列酮预处理可显著阻止点燃的进展。与 PTZ 组相比,罗格列酮治疗的小鼠 MDA 水平降低,CAT 和 SOD 水平升高(P<0.01)。实时 PCR 和 Western blot 分析也得到了类似的结果。大脑中 IL-1β、IL-6、IL-10、IFN-γ、TNF-α、Bax 或 PPAR-γ 的表达水平发生了显著变化。这项研究的结果表明,罗格列酮的作用可能与其保护 PTZ 诱导的癫痫发作引起的神经元损伤的能力有关。